Primary Peritoneal Carcinoma

Description

Primary peritoneal carcinoma (PPC) is a rare malignant tumor of the peritoneal cavity of extra-ovarian origin, clinically and histologically similar to advanced-stage serous ovarian carcinoma (see this term).

Clinical Features

Phenotypes and symptoms related to Primary Peritoneal Carcinoma

  • Neoplasm
  • Constipation
  • Abdominal pain
  • Nausea and vomiting
  • Abdominal distention
  • Peritonitis

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Primary Peritoneal Carcinoma Is also known as primary peritoneal serous carcinoma, extra-ovarian primary peritoneal carcinoma, eoppc, serous surface papillary carcinoma, ppc.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Primary Peritoneal Carcinoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
BRCA1.

By Molecular Diagnostic Laboratory University of Alberta (Canada).

BRCA1
Specificity
100 %
Genes
100 %
MitoMetĀ®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2
Specificity
50 %
Genes
100 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2
Specificity
50 %
Genes
100 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 %
Hereditary Prostate Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

BRCA1, BRCA2, TP53, NBN
Specificity
25 %
Genes
100 %
Hereditary Pancreatic Cancer Panel.

By Baylor Miraca Genetics Laboratories (United States).

BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDK4, CDKN2A, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, ATM, PMS2, RAD50
Specificity
6 %
Genes
100 %

We have 346 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more